Researchers conducted a review of existing studies to examine a specific type of MRI scan called pseudocontinuous arterial spin-labeling (pCASL). This technique measures blood flow in the brain without needing an injected dye. The review focused on how reliable this method is for people who have had an ischemic stroke and how it compares to other common imaging tests like contrast-enhanced MRI or CT perfusion scans.
The analysis included data from 383 stroke patients across multiple studies. The main finding was that in the very early hours after a stroke (the hyperacute phase), pCASL measurements of damaged brain tissue and low blood flow areas showed no significant differences compared to a standard contrast MRI method. This suggests the two methods might give similar results for these specific measurements during that critical time window.
However, the researchers strongly caution that the overall evidence is very thin. Only one study, which was considered low quality, looked at whether pCASL gives consistent results when repeated. There were not enough studies to draw firm conclusions about how pCASL compares to other techniques in different stages after a stroke or to methods like PET scans. No safety concerns were specifically reported in the review.
Readers should understand that this review highlights early, incomplete evidence. It suggests pCASL could be a useful tool for stroke imaging, but the findings are not yet strong enough to change clinical practice. More and better-quality studies are necessary to confirm if this dye-free MRI technique is truly reliable and comparable to current standard methods.